UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 150

Sortiert nach

U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies

Nature cell biology, 2019-05, Vol.21 (5), p.640

2019

Link zum Volltext

Verfügbarkeit prüfen

Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications

Advances in biological regulation, 2017-01, Vol.63, p.59-70

2017

Link zum Volltext

Verfügbarkeit prüfen

Application of CRISPR/Cas9 genome editing to the study and treatment of disease

Archives of toxicology, 2015-07, Vol.89 (7), p.1023-1034

2015

Link zum Volltext

Verfügbarkeit prüfen

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

Nature genetics, 2010-08, Vol.42 (8), p.722-726

2010

Link zum Volltext

Verfügbarkeit prüfen

Cell-specific proteome analyses of human bone marrow reveal molecular features of age-dependent functional decline

Nature communications, 2018-10, Vol.9 (1), p.4004-18, Article 4004

2018

Link zum Volltext

Verfügbarkeit prüfen

Identification of a BRCA1-mRNA Splicing Complex Required for Efficient DNA Repair and Maintenance of Genomic Stability

Molecular cell, 2014-05, Vol.54 (3), p.445-459

2014

Link zum Volltext

Verfügbarkeit prüfen

Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin Activation

Cancer research (Chicago, Ill.), 2017-09, Vol.77 (18), p.4846-4857

2017

Link zum Volltext

Verfügbarkeit prüfen

S02 - Presentation Name: Insights from the MDS transcriptome: MDS DISEASE PROGRESSION: INSIGHTS FROM THE TRANSCRIPTOME

Leukemia research, 2021-09, Vol.108

Boultwood, Jacqueline

2021

Link zum Volltext

Verfügbarkeit prüfen

Presentation Name: Insights from the MDS transcriptome

Leukemia research, 2021-09, Vol.108, p.106682, Article 106682.2

Boultwood, Jacqueline

2021

Link zum Volltext

Verfügbarkeit prüfen

Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic Syndromes

Cell reports (Cambridge), 2017-07, Vol.20 (3), p.572-585

2017

Link zum Volltext

Verfügbarkeit prüfen

Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients

Proceedings of the National Academy of Sciences - PNAS, 2007-07, Vol.104 (27), p.11406-11411

2007

Link zum Volltext

Verfügbarkeit prüfen

The role of haploinsufficiency of RPS14 and p53 activation in the molecular pathogenesis of the 5q- syndrome

Pediatric reports, 2011-06, Vol.3 Suppl 2 (12), p.e10-e10

Boultwood, Jacqueline

2011

Link zum Volltext

Verfügbarkeit prüfen

ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts

Oncotarget, 2015-12, Vol.6 (42), p.44061-44071

2015

Link zum Volltext

Verfügbarkeit prüfen

Impact of Splicing Factor Mutations on Pre-mRNA Splicing in the Myelodysplastic Syndromes

Current pharmaceutical design, 2016-05, Vol.22 (16), p.2333

2016

Link zum Volltext

Verfügbarkeit prüfen

Phospholipase C beta1 (PI‐PLCbeta1)/Cyclin D3/protein kinase C (PKC) alpha signaling modulation during iron‐induced oxidative stress in myelodysplastic syndromes (MDS)

The FASEB journal, 2020-11, Vol.34 (11), p.15400-15416

2020

Link zum Volltext

Verfügbarkeit prüfen

Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches

Advances in biological regulation, 2018-01, Vol.67, p.13-29

2018

Link zum Volltext

Verfügbarkeit prüfen

Identification of Gene Expression–Based Prognostic Markers in the Hematopoietic Stem Cells of Patients With Myelodysplastic Syndromes

Journal of clinical oncology, 2013-10, Vol.31 (28), p.3557-3564

2013

Link zum Volltext

Verfügbarkeit prüfen

TP53 suppression promotes erythropoiesis in del(5q) MDS, suggesting a targeted therapeutic strategy in lenalidomide-resistant patients

Proceedings of the National Academy of Sciences - PNAS, 2013-10, Vol.110 (40), p.16127-16132

2013

Link zum Volltext

Verfügbarkeit prüfen

Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromes

Proceedings of the National Academy of Sciences - PNAS, 2015-11, Vol.112 (46), p.E6359-E6368

2015

Link zum Volltext

Verfügbarkeit prüfen

Splicing factor mutations in the myelodysplastic syndromes: Role of key aberrantly spliced genes in disease pathophysiology and treatment

Advances in biological regulation, 2023-01, Vol.87, p.100920-100920, Article 100920

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 150

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Full Collection 2018

ThemaHematology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(146)
Mit Volltextzugriff
(142)

Publikationsform

Artikel
(150)

Sprache

Englisch
(150)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

Humans
(56)
Science & Technology
(46)
Life Sciences & Biomedicine
(38)
Myelodysplastic Syndromes - Genetics
(30)
Mutation
(23)
Myelodysplastic Syndromes
(19)
Animals
(18)
Medicin Och Hälsovetenskap
(17)
Myelodysplastic Syndromes - Metabolism
(16)
Cell Biology
(15)
Gene Expression
(15)
Genes
(14)
Male
(14)
Myelodysplastic Syndrome
(14)
Myelodysplastic Syndromes - Pathology
(14)
Female
(13)
Oncology
(13)
Biological And Medical Sciences
(11)
Chromosome Deletion
(11)
Rna Splicing
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies

Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications

Application of CRISPR/Cas9 genome editing to the study and treatment of disease

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia

Cell-specific proteome analyses of human bone marrow reveal molecular features of age-dependent functional decline

SIRT1 Activation Disrupts Maintenance of Myelodysplastic Syndrome Stem and Progenitor Cells by Restoring TET2 Function

Identification of a BRCA1-mRNA Splicing Complex Required for Efficient DNA Repair and Maintenance of Genomic Stability

Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin Activation

S02 - Presentation Name: Insights from the MDS transcriptome: MDS DISEASE PROGRESSION: INSIGHTS FROM THE TRANSCRIPTOME

Presentation Name: Insights from the MDS transcriptome

Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic Syndromes

Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations

Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients

The role of haploinsufficiency of RPS14 and p53 activation in the molecular pathogenesis of the 5q- syndrome

ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts

Impact of Splicing Factor Mutations on Pre-mRNA Splicing in the Myelodysplastic Syndromes

Phospholipase C beta1 (PI‐PLCbeta1)/Cyclin D3/protein kinase C (PKC) alpha signaling modulation during iron‐induced oxidative stress in myelodysplastic syndromes (MDS)

Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches

BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initiating Cells with Differential Regulation of Relevant Genes Leading to Extended Survival in a NRAS/BCL-2 Mouse Model of High Risk-Myelodysplastic Syndrome

Identification of Gene Expression–Based Prognostic Markers in the Hematopoietic Stem Cells of Patients With Myelodysplastic Syndromes

TP53 suppression promotes erythropoiesis in del(5q) MDS, suggesting a targeted therapeutic strategy in lenalidomide-resistant patients

TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia

Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromes

Splicing factor mutations in the myelodysplastic syndromes: Role of key aberrantly spliced genes in disease pathophysiology and treatment

Aktive Filter

Suchergebnisse filtern